WASHINGTON (AP) — U.S. health officials are investigating low levels of a potentially dangerous contaminant in the popular heartburn medication Zantac and related drugs.
For now, the Food and Drug Administration said patients can continue taking their medications.
The agency said Friday it has detected a “probable” cancer-causing chemical in the medications, which are sold as both prescription and over-the-counter treatments.
FDA officials said the amount of the contaminant barely exceeds levels found in common foods. But the same chemical has been linked to dozens of recalls of blood pressure drugs in the past year. The FDA is still investigating that issue and last month sanctioned a manufacturing plant in India that makes some of the medications.
Roughly 80 percent of the ingredients used in U.S. drugs are manufactured overseas.
- Cheating during remote testing is a problem, but now there’s a fix
- ‘I’m ready to talk,’ Meghan Markle says ahead of Oprah interview
- Report: Popular flea & tick collar tied to 1,700 pet deaths, EPA received more than 75,000 complaints
- See inside this incredible 1940’s-era Art Deco home that just hit the market
- Depression forms after car hits fire hydrant, causes water leak in Tampa